레포트 목록으로 돌아가기
weekly

주간 내부자 리뷰: 02/01 - 02/08

분석 기간: 2026-02-01 ~ 2026-02-08

2026년 2월 8일5분 소요0 views
총매수액
$55.3M
149건의 거래
총매도액
$1.1B
877건의 거래
매수/매도 비율
0.17
약세
평균 BQS
0.0
0건의 BQS 80+ 거래

주목할 매수

클릭하여 상세 분석 표시

NFRX
👤Harrison Street Real Assets Fund LLC
Other
$9,999,998
390,320주 @ $25.62
거래 규모
매우 큰 거래 규모로 강한 확신을 시사
직책의 의미
경영 간부의 거래
시그널 판정
강한 매수 시그널. 자발적인 대형 매수는 내부자의 강한 확신을 나타냄
NFRX
👤Harrison Street Real Assets Fund LLC
Other
$9,999,998
390,320주 @ $25.62
NONE
👤Neuberger Berman Group LLC
Other
$8,000,000
797,607주 @ $10.03
EIKN
👤Lux Venture Partners V, LLC
Other
$2,499,984
138,888주 @ $18.00
EIKN
👤Wolfe Josh
Other
$2,499,984
138,888주 @ $18.00

위험 요소

대형 매도 및 주의할 움직임

BANC
👤WARBURG PINCUS LLC
Other
$151,158,720
7,557,936주 @ $20.00
BANC
👤WARBURG PINCUS LLC
Other
$65,841,280
3,292,064주 @ $20.00
HTFL
👤Bain Capital Life Sciences Investors, LLC
Other
$56,100,000
2,000,000주 @ $28.05
KO
📊Quincey James
Director
$26,046,095
337,824주 @ $77.10
KO
📊Quincey James
Director
$26,046,095
337,824주 @ $77.10

AI 시장 분석

AI에 의한 시장 분석 및 인사이트

Weekly Insider Trading Report: February 1 - February 8, 2026

Executive Summary

  • During the week, insider trading activity showed a significant discrepancy between buying and selling, with 149 buy transactions totaling $55,281,298.82 and 877 sell transactions amounting to $1,110,677,406.36. This results in a buy/sell ratio of 0.17.
  • The largest single buy was by Harrison Street Real Assets Fund LLC, acquiring 390,320 shares of NFRX for $9,999,998.40 on February 5, indicating strong confidence in the stock.
  • Notable selling activity was led by WARBURG PINCUS LLC, which executed multiple transactions totaling $231,158,720.00 for shares in BANC, reflecting potential bearish sentiment in the market.
  • The healthcare and biotech sectors showed strong insider buying activity, while financial services experienced heavy selling, suggesting sector-specific trends.
  • Overall, the week exhibited a cautious market sentiment with insiders opting to sell significantly more than they were buying.

Top Conviction Buys

This section highlights significant non-10b5-1 purchases made by insiders, indicating a strong belief in the potential growth of these companies:

  1. NFRX

    • Insider: Harrison Street Real Assets Fund LLC
    • Transaction Type: Buy
    • Total Value: $9,999,998.40 (390,320 shares at $25.62)
    • Trade Date: February 5, 2026
    • Notes: Repeated purchase on the same date, showcasing high conviction.
  2. NONE

    • Insider: Neuberger Berman Group LLC
    • Transaction Type: Buy
    • Total Value: $8,000,000.00 (797,607 shares at $10.03)
    • Trade Date: February 4, 2026
    • Notes: Significant investment indicating strong confidence in the underlying asset.
  3. EIKN

    • Insider: Wolfe Josh
    • Transaction Type: Buy
    • Total Value: $2,499,984.00 (138,888 shares at $18.00)
    • Trade Date: February 4, 2026
    • Notes: Non-10b5-1 purchase, indicative of a forecasted positive outlook.
  4. LXRX

    • Insider: Invus Global Management, LLC
    • Transaction Type: Buy
    • Total Value: $2,000,000.60 (1,538,462 shares at $1.30)
    • Trade Date: February 2, 2026
    • Notes: Large volume purchase suggesting confidence in the company's future performance.

Risk Radar

This section reviews notable sells and potential warning signs indicating caution in specific sectors:

  1. BANC

    • Insider: WARBURG PINCUS LLC
    • Transaction Type: Sell
    • Total Value: $151,158,720.00 (7,557,936 shares at $20.00) on February 2, 2026.
    • Notes: Multiple transactions within the same week reflect a significant exit, raising concerns about the company's immediate outlook.
  2. KO (Coca-Cola)

    • Insider: Quincey James
    • Transaction Type: Sell
    • Total Value: $26,046,095.27 (337,824 shares at $77.10) on February 3, 2026.
    • Notes: Repeated sell transactions indicate a strategy to capitalize on current stock prices, suggesting potential weakness.
  3. SYK (Stryker Corporation)

    • Insider: STRYKER RONDA E
    • Transaction Type: Sell
    • Total Value: $24,893,630.21 (68,688 shares at $362.42) on February 5, 2026.
    • Notes: Several large sell-offs suggest a lack of confidence in the near-term performance of this medical device company.

Market Sentiment Analysis

The current market sentiment appears cautious, characterized by a disproportionate number of sell transactions relative to buys. The buy/sell ratio of 0.17 highlights a bearish outlook among insiders, especially in the financial sector, where significant sell-off activity was observed. The substantial volume of insider sales may indicate a belief that stock prices have reached their peak or that negative information could be on the horizon.

Conversely, concentrated buying in the healthcare and biotech sectors suggests pockets of opportunity amidst the overall cautious sentiment, with insiders betting on specific companies' future performance despite a broader market pullback.

Investment Opportunities

Given the current landscape, investors might consider focusing on sectors where insider buying is prevalent, such as healthcare and biotech, as these may offer potential growth opportunities. Notably:

  • NFRX and EIKN exhibit strong insider buying, suggesting they could be undervalued or poised for growth.
  • Monitoring LXRX could yield potential returns, especially if the stock price begins to trend positively following the substantial insider purchase.
  • Caution should be exercised in the financial sector, particularly regarding companies with significant insider selling activity, such as BANC and KO. Investors may wish to explore alternative sectors or companies with more favorable insider activity.

Overall, a balanced approach that includes careful analysis of insider trading along with market trends and sector performance will be vital in navigating the investment landscape in the coming weeks.

데이터 출처 및 면책조항 (Disclaimer)

  • 데이터는 SEC Form 4 공개 정보에 기반합니다
  • 10b5-1 플랜: 사전에 설정된 자동 매매 계획(시그널 효과는 제한적)
  • 본 리포트는 정보 제공만을 목적으로 하며, 투자 조언이 아닙니다